Search Results

240 results for NTRI

Thursday’s Stocks to Watch: Constellation Energy, Starbucks

Constellation Energy (CEG) catches a bid on a merger agreement.

Forget Food Fads — Profit From Pills

If you’re looking to profit off an increasingly health-conscious America, avoid the diet-centered companies and head for the supplement aisle instead.

The Nvidia Acquisition Rumor Shouldn’t Be Ignored

The Nvidia acquisition rumor may be false, but it reveals a real shift toward edge AI, inference chips, and rising competition.

Bespoke Co-Founder Reveals His “Triple Play” Stocks

My fundamentally superior stocks have been much stronger than normal lately. I keep checking my pulse just to make sure I’m not dreaming. To explain…

The 10 Best Stocks to Buy Right Now for 2018

It’s always good to buy quality, especially when they’re growing like this. And these are the 10 best stocks to buy right now for the…

HLF – There Is Plenty to Like About ‘Boring’ Herbalife Stock

Barron’s declared that hedge-fund battleground Herbalife has gotten boring these days — and that’s great news for investors in HLF stock.

3 Personal Products Stocks to Buy as the Market Dips

These three personal product stocks should bounce-back from near-term weakness due to robust consumer strength.

4 Stocks That Will Benefit From the Weight Crisis

Weight Watchers, NutriSystem, Sprouts Farmers Market and United Natural Foods will benefit as Americans look for healthier foods in reaction to the U.S. obesity epidemic.

Buy Medifast Stock as It Continues to Soar

Medifast stock is gaining while its customers lose big — in a good way. This weight-loss stock may not be a household name, but there…

China Clips U.S. Markets — Monday’s IP Market Recap

Beijing lowered its official growth target from 8% to 7.5%, and that helped cool off stocks.

In Case You Missed Thursday

Consult oil prices to know which way the market is headed.

Stop Asking Where the Market Is Headed

In today’s Saturday Digest, Keith Kaplan explains why some of the most successful investors in history – including legendary hedge fund manager Jim Simons –…

5 Soaring Stocks With Yields Over 5%

Investors drool over dividend stocks with high yields and the potential for share appreciation. So far this year, these five companies have fit the bill.

These AI Patterns Are 100x More Important Than the Strait of Hormuz

Yesterday, we looked at how AI is starting to uncover patterns in market data that most investors simply can’t see. Today, Keith Kaplan takes that…

ETFs: What Are You Really Buying?

When exchange-traded funds get really niche, some stretch to provide a range of holdings. Here’s a look at some of the oddball holdings in ETFs.

Gold or Silver – Which Do You Buy Right Now?

The gold-to-silver ratio resets to equilibrium… Luke’s case for a silver melt-up… Eric’s case for gold… the fiscal disorder fueling the longer-term bet… so, which…

ZNGA Beats Earnings, But Don’t Buy Zynga Stock Yet

Zynga scored better-than-expected earnings, and Zynga stock jumped because of it. But the real test is its new franchise-based strategy.

3 High-Yielders to Avoid Like the Plague

A yield north of 4% may look enticing, but you have to dig a little deeper before plunging in. These three stocks aren’t worth your…

20 2018 Losers That Will Be Big Winners

These 20 stocks have fallen at least 5% so far this year but should have better prospects ahead.

The Sad Skinny On Obesity-Drug Stocks

Obesity drugs have yet to produce a big payday.

Why Weight Watchers International, Inc. (WTW), Valeant Pharmaceuticals Intl. Inc. (VRX) and Gap Inc. (GPS) Are 3 of Today’s Worst Stocks

The week couldn’t end soon enough for Weight Watchers International, Inc. (WTW), Valeant Pharmaceuticals Intl. Inc. (VRX) and Gap Inc. (GPS).

3 Huge Healthcare Trends Can Fatten Your Portfolio

Healthcare concerns in the U.S. are being addressed by companies in the industry. These 3 issues can lead investors to stock opportunities

Should I Buy Weight Watchers? 3 Pros, 3 Cons

Weight Watchers has many things going for it and could get a lift from Obamacare — but is it a good buy? Here’s the verdict.

Forget Neuralink: The Real Brain Tech Trade Has 10 Names You’ve Never Heard

7 – 10 of 240 results